StockData

Enova International vs Regional Management

ENVA and RM side by side, both in personal credit institutions. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ENVA and RM compare

Enova International is the larger company, worth 13 times as much as Regional Management ($4.3B against $335M).

On earnings, Regional Management is cheaper: it trades at 7.6× trailing earnings, against 12.9× for Enova International.

Enova International grew revenue faster over the last twelve months (17.7% versus 9.6% for Regional Management).

Enova International keeps more of each dollar of sales as profit, with a net margin of 10.3% compared with 7.0% at Regional Management.

Regional Management pays a dividend yielding 3.3%; Enova International does not pay one.

Regional Management scores higher on the StockData Score (14 against 9 for Enova International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricENVARM
Size and price
Market cap$4.3B$335M
Share price$174.09$36.30
Change, 1 year43.4%−7.0%
Change, 5 years330%−39.0%
Beta (5Y)1.391.09
Employees1,8362,112
StockData Score
Total score914 (better)
Valuation score16 (better)
Growth score5 (better)1
Performance score3 (better)1
Health score04 (better)
Dividend score02 (better)
Valuation
P/E12.9×7.6× (better)
P/S1.3×0.5× (better)
P/B2.9×0.9× (better)
EV/EBITDA4.9×4.2× (better)
P/FCF2.2×1.0× (better)
PEG0.56–
FCF yield45.1%96.6% (better)
Fair value$216.23$48.10
Margin of safety19.5%24.5% (better)
Growth
Revenue growth (TTM)17.7% (better)9.6%
Revenue growth, 5Y average23.8% (better)11.5%
Net income growth (TTM)38.7% (better)34.8%
EPS growth (TTM)43.1% (better)36.9%
EPS growth, 5Y average−0.31%13.1% (better)
Profitability
Gross margin59.8%–
Operating margin24.0%–
Net margin10.3% (better)7.0%
FCF margin56.7% (better)48.2%
Return on equity26.1% (better)12.6%
Return on invested capital50.0%–
Financial health
Debt / equity–0.00
Interest coverage2.3×–
Altman Z-score1.74 (better)0.71
Piotroski F-score8 (better)5
Dividends and buybacks
Dividend yield–3.3%
Years of dividend growth–0
Dividend growth, 5Y average–43.1%
Buyback yield3.1%7.5% (better)
Shareholder yield3.1%10.8% (better)
Ownership
Held by institutions94.7%88.7%
Held by insiders5.5%23.0%
Insider net buying, 12 months−$59.9M−$18.6M (better)
Short interest, % of float8.0%4.8%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.